Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Scholar Rock Holding Corp
2QKCurrent price
25.6 EUR
+0.2 EUR (+0.79%)
Last closed
27.5 USD
Company
scholarrock.com
ISIN
US80706P1030
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
2 672 190 208 USD
Yield for 12 month
+125.26 %
1Y
3Y
5Y
10Y
15Y
2QK
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts. Address: 301 Binney Street, Cambridge, MA, United States, 02142
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
37.38 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+33 193 000 USD
Current Quarter
–
Last Quarter
–
Current Year
-2 844 000 USD
Last Year
+33 193 000 USD
Current Quarter
-498 000 USD
Last Quarter
-598 000 USD
Key Figures 2QK
1 year
3 years
5 years
10 years
EBITDA
-207 144 992 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-51.2 %
PEG Ratio
–
Return On Equity TTM
-121.29 %
Wall Street Target Price
37.38 USD
Revenue TTM
–
Book Value
1.67 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
-89 851 000 USD
Earnings per share
-2.22 USD
Diluted Eps TTM
-2.22 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 2QK
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 2QK
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 2QK
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
8.22
Price Sales TTM
13.1358
Enterprise Value EBITDA
-2.0767
Price Book MRQ
19.9984
Financials 2QK
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 2QK
For 52 weeks
6.76 USD
35.38 USD
50 Day MA
18.76 USD
Shares Short Prior Month
16 516 069
200 Day MA
13.89 USD
Short Ratio
3.84
Shares Short
14 928 341
Short Percent
31.58 %
BeatStart